Prostate Cancer

Prostate Cancer Drug Pipeline Analysis and Market Forecasts to 2015

Summary

GlobalData, the industry analysis specialist's new report, ""Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015"" is an essential source of information and analysis on the global prostate cancer market. The report identifies the key trends shaping and driving the global prostate cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global prostate cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope

The scope of the report includes:

• Annualized global prostate cancer market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
• Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
• Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
• Analysis of the current and future market competition in the global prostate cancer market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with prostate cancer.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

• Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global prostate cancer market.
• Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global prostate cancer market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What's the next big thing in the global prostate cancer market landscape? - Identify, understand and capitalize.

• 1 Prostate Cancer Market: Executive Summary
• 2 Table of Contents
  • 2.1 List of Tables
  • 2.2 List of Figures
• 3 Prostate Cancer Market: Market Characterization
  • 3.1 Overview
  • 3.2 Prostate Cancer Market Size
  • 3.3 Prostate Cancer Market Forecast and CAGR
  • 3.4 Drivers and Barriers for Prostate Cancer Market
    • 3.4.1 Drivers for Prostate Cancer Market
    • 3.4.2 Barriers for Prostate Cancer Market
  • 3.5 Opportunity and Unmet Need
  • 3.6 Key Takeaway
• 4 Prostate Cancer Market: Competitive Assessment
  • 4.1 Overview
  • 4.2 Strategic Competitor Assessment
  • 4.3 Product Profiles of the Major Marketed Products
    • 4.3.1 Overview
    • 4.3.2 Efficacy
    • 4.3.3 Safety Profile
    • 4.3.4 Pricing
    • 4.3.5 Clinical Study Details
  • 4.4 Key Takeaway
• 5 Prostate Cancer Market: Pipeline Assessment
  • 5.1 Overview
  • 5.2 Strategic Pipeline Assessment
    • 5.2.1 Technology Trends Analytical Framework
  • 5.3 Prostate Cancer Therapeutics - Promising Drugs under Clinical Development
  • 5.4 Molecule Profiles of Promising Drugs under Clinical Development
    • 5.4.1. Overview
    • 5.4.2 Efficacy
    • 5.4.3 Safety
    • 5.4.4 Clinical Study Details
  • 5.5 Prostate Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action
  • 5.6 Prostate Cancer Pipeline - Pipeline by Clinical Phases of Development
    • 5.6.1 Prostate Cancer Therapeutics - Phase III Clinical Pipeline
    • 5.6.2 Prostate Cancer Therapeutics - Phase II Clinical Pipeline
    • 5.6.3 Prostate Cancer Therapeutics - Phase I Clinical Pipeline
    • 5.6.4 Prostate Cancer Therapeutics - Preclinical Pipeline
    • 5.6.5 Prostate Cancer Therapeutics - Discovery Pipeline
  • 5.7 Discontinued / Suspended Drugs for Prostate Cancer
  • 5.8 Key Takeaway
• 6 Prostate Cancer Market: Implications for Future Market Competition
• 7 Prostate Cancer Market: Future Players in Prostate Cancer Market
• 8 Prostate Cancer Market: Appendix
  • 8.1 Definitions
  • 8.2 Acronyms
  • 8.3 Research Methodology
    • 8.3.1 Coverage
    • 8.3.2 Secondary Research
    • 8.3.3 Forecasting
      • 8.3.3.1 Epidemiology-based Forecasting
    • 8.3.4 Primary Research
    • 8.3.5 Expert Panel validation
  • 8.4 Contact Us
  • 8.5 Disclaimer
  • 8.6 Sources
• List of Tables
  • Table 1: Global Prostate Cancer Treatment by Stage of the Disease, 2009
  • Table 2: Global Prostate Cancer Therapeutics Market, Revenue Forecasts ($ m), 2000-2008
  • Table 3: Global Prostate Cancer Therapeutics Market, Revenue Forecasts ($ m), 2009-2015
  • Table 4: Major marketed products comparison in Prostate Cancer, 2009
  • Table 5: Prostate Cancer Therapeutics - Most Promising Drugs Under Clinical Development, 2009
  • Table 6: Prostate Cancer Therapeutics - Phase III Clinical Pipeline, 2009
  • Table 7: Prostate Cancer Therapeutics - Phase II Clinical Pipeline, 2009
  • Table 8: Prostate Cancer Therapeutics - Phase I Clinical Pipeline, 2009
  • Table 9: Prostate Cancer Therapeutics - Preclinical Pipeline, 2009
  • Table 10: Prostate Cancer Therapeutics - Drug Discovery Pipeline, 2009
  • Table 11: Prostate Cancer Therapeutics - List of Discontinued Drugs, 2009
• List of Figures
  • Figure 1: Global Prostate Cancer Therapeutics Market Forecast, 2000-2015
  • Figure 2: Prostate Cancer Therapeutics Market - Opportunity and Unmet Need, 2009
  • Figure 3: Prostate Cancer Therapeutics Market - Strategic Competitor Assessment, 2009
  • Figure 4: Technology Trends Analytic Framework of the Prostate Cancer Pipeline, 2009
  • Figure 5: Technology Trends Analytic Framework of the Prostate Cancer Pipeline - Description, 2009
  • Figure 6: Prostate Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2009
  • Figure 7: Prostate Cancer Pipeline by Phase of Clinical Development, 2009
  • Figure 8: Prostate Cancer Therapeutics Market - Strategic Competitor Assessment, 2009
  • Figure 9: Prostate Cancer Therapeutics Market - Clinical Pipeline by Company, 2009
  • Figure 10: GlobalData Methodology
  • Figure 11: GlobalData Market Forecasting Model